Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Stet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Klinische Padiatrie|July 1, 1992
Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblastsJ P Bökkerink, R A De Abreu, E H Stet, et al.
Biochimica Et Biophysica Acta|January 22, 1993
A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell lineE H Stet, R A De Abreu, Y P Janssen, et al.
Biochimica Et Biophysica Acta|April 30, 1993
The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblastsM H Vogt, E H Stet, R A De Abreu, et al.
Biochemical Pharmacology|August 3, 1993
Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Biochemical Pharmacology|April 6, 1993
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblastsJ P Bökkerink, E H Stet, R A De Abreu, et al.
Biochemical Pharmacology|January 6, 1995
Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenineE H Stet, R A De Abreu, J P Bökkerink, et al.
Annals of Clinical Biochemistry|March 1, 1994
Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Biochemical Pharmacology|September 28, 1995
The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphateA A van Berg, P A Mooyer, H van Lenthe, et al.
The Biochemical Journal|November 15, 1994
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Klinische Padiatrie|July 1, 1992
Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblastsJ P Bökkerink, R A De Abreu, E H Stet, et al.
Biochimica Et Biophysica Acta|January 22, 1993
A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell lineE H Stet, R A De Abreu, Y P Janssen, et al.
Biochimica Et Biophysica Acta|April 30, 1993
The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblastsM H Vogt, E H Stet, R A De Abreu, et al.
Biochemical Pharmacology|August 3, 1993
Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Biochemical Pharmacology|April 6, 1993
6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblastsJ P Bökkerink, E H Stet, R A De Abreu, et al.
Biochemical Pharmacology|January 6, 1995
Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenineE H Stet, R A De Abreu, J P Bökkerink, et al.
Annals of Clinical Biochemistry|March 1, 1994
Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Biochemical Pharmacology|September 28, 1995
The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphateA A van Berg, P A Mooyer, H van Lenthe, et al.
The Biochemical Journal|November 15, 1994
Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblastsE H Stet, R A De Abreu, J P Bökkerink, et al.
Pageof 1